Cited by 48Fibromyalgia and Chronic Fatigue Syndrome ResearchMetabolomics and Mass Spectrometry StudiesGut microbiota and health

The GC-MS metabolomics signature in patients with fibromyalgia syndrome directs to dysbiosis as an aspect contributing factor of FMS pathophysiology

Malatji, Bontle G., Mason, Shayne, Mienie, Lodewyk J., Wevers, Ron A., Meyer, Helgard, van Reenen, Mari, Reinecke, Carolus J.·2019·Metabolomics

Abstract

Introduction Fibromyalgia syndrome (FMS) is a chronic pain syndrome. Previous analyses of untargeted metabolomics data indicated altered metabolic profile in FMS patients.Objectives We report a semi-targeted explorative metabolomics study on the urinary metabolite profile of FMS patients; exploring the potential of urinary metabolite information to augment existing medical diagnosis.Methods All cases were females. Patients had a medical history of persistent FMS (n = 18). Control groups were first-generation family members of the patients (n = 11), age-related individuals without indications of FMS (n = 10), and healthy, young (18-22 years) individuals (n = 41). The biofluid investigated was early morning urine samples. Data generation was done through gas chromatography-mass spectrometry (GC-MS) analysis and data processing and analyses were performed using Matlab, R, SPSS and SAS software.Results Quantitative analysis revealed the presence of 196 metabolites. Unsupervised and supervised multivariate analyses distinguished all three control groups and the FMS patients, which could be related to 14 significantly increased metabolites. These metabolites are associated with energy metabolism, digestion and metabolism of carbohydrates and other host and gut metabolites.Conclusions Overall, urinary metabolite profiles in the FMS patients suggest: (1) energy utilization is a central aspect of this pain disorder, (2) dysbiosis seems to prevail in FMS patients, indicated by disrupted microbiota metabolites, supporting the model that microbiota may alter brain function through the gut-brain axis, with the gut being a gateway to generalized pain, and (3) screening of urine from FMS is an avenue to explore for adding non-invasive clinical information for diagnosis and treatment of FMS.

Integrity signals

Registry

Crossref · 10.1007/s11306-019-1513-6

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Probiotics have been shown to improve cognitive symptoms and biochemical markers in participants with various dysbiosis-related disorders, including Alzheimer's disease, fibromyalgia, and irritable bowel syndrome.

    “Probiotics have been shown to improve cognitive symptoms and biochemical markers in participants with various dysbiosis-related disorders, including Alzheimer’s disease (476), fibromyalgia (477, 478), and irritable bowel syndrome (IBS) (479).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Malatji, B. G., Mason, S., Mienie, L. J., Wevers, R. A., Meyer, H., van Reenen, M., & Reinecke, C. J.
Affiliations
  • North-West University (ZA)
  • Radboud University Medical Center (NL)
  • Kalafong Hospital (ZA)
Corresponding author
Mason, Shayne
Venue
Metabolomics
Published
2019-03-27
Volume
15
Issue
4
Pages
54-54
ISSN
  • 1573-3882 (ISSN-L)
  • 1573-3890
OpenAlex
W2923029396
Cited by
48
References
57
Citations by year
2026: 3 · 2025: 8 · 2024: 3 · 2023: 9 · 2022: 5 · 2021: 7 · 2020: 11 · 2019: 2
FWCI
5.00
Type
journal article
Language
en
Open access
closed
Locations
  • Metabolomics (publishedVersion)
  • PubMed (publishedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
  • UpSpace Institutional Repository (University of Pretoria) (submittedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
fibromyalgia, gut dysbiosis, gut microbiota metabolites, gut-brain axis, energy metabolism, chronic pain, non-invasive diagnosis, metabolomics biomarkers
MeSH terms
Adult, Female, Fibromyalgia, Humans, Gas Chromatography-Mass Spectrometry, Middle Aged, Biomarkers, Multivariate Analysis, Metabolomics, Metabolome, Young Adult, Dysbiosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review